Healthcare Innovations, 14

Back to All Secondary Trusts
SymbolSMHCNX
Term2 Year
Prospectus
Fact Card
The trust seeks total return potential primarily through capital appreciation. There is no guarantee that the investment objectives of the trust will be achieved.

  • Description

    • Status Secondary
    • Category Equity Oriented Portfolio
    • Objective Total Return

  • Pricing (06-05-2023)

    • Bid Price $11.7351
    • Liquidation Price $11.5851

  • Deposit Data

    • Deposit Date 11-04-2022
    • Termination Date 11-05-2024
    • Initial Offer Price $10.00
    • Max Sales Charge 2.75%

  • CUSIPs

    • Cash 83193L460
    • Reinvest 83193L478
    • Fee - Cash 83193L486
    • Fee - Reinvest 83193L494

  • Historical 12-Month Distribution*

    • Pay FrequencyMonthly (if any)

  • Sector Breakdown (As of Deposit Date)

  • Pricing Summary (As of 06-05-2023)

*The Historical 12-Month Distribution of Trust Holdings is as of 01/01/2023. If the Trust deposited after, or 90 days prior to, 01/01/2023, the distribution is as of deposit date. The Historical 12-Month Distribution is calculated by taking the weighted average of the regular income distributions paid by the securities included in the trust’s portfolio over the 12 months preceding the trust’s date of deposit reduced to account for the effects of trust fees and expenses. This historical distribution is for illustrative purposes only and is not indicative of amounts that will actually be distributed by the trust. The distributions paid by the trust may be higher or lower than the amount shown above due to factors including, but not limited to, changes in the price of trust units, changes (including reductions) in distributions paid by issuers, changes in actual trust expenses and sales of securities in the portfolio. There is no guarantee that the issuers of the securities included in the trust will pay any distributions in the future.